{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:08:39Z","timestamp":1780466919113,"version":"3.54.1"},"reference-count":126,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2016,12,1]]},"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:p>Improving neurodevelopmental outcome for preterm infants is an important challenge for neonatal medicine. The disruption of normal brain growth and neurological development is a significant consequence of preterm birth and can result in physical and cognitive impairments. While advances in neonatal medicine have led to progressively better survival rates for preterm infants, there has only been a modest improvement in the proportion of surviving infants without neurological impairment, and no change in the proportion with severe disability. The overall number of children with neurodisability due to prematurity is increasing. Trials investigating novel therapies are underway and many have promising early results; however, in the interim, current treatments and management strategies that have proven benefit for neurodevelopment or reduction in neonatal brain injury are often underutilised. We collate the evidence for the efficacy of such interventions, recommended by guidelines or supported by large meta-analysis or randomised control trials. We address controversies that have hindered uptake and problems with translating research into practice. We then look to the future of preterm neuroprotective care.<\/jats:p>","DOI":"10.1136\/archdischild-2016-311949","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T14:40:34Z","timestamp":1482590434000},"page":"F176-F182","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":31,"title":["Protecting the premature brain: current evidence-based strategies for minimising perinatal brain injury in preterm infants"],"prefix":"10.1136","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5103-2457","authenticated-orcid":false,"given":"Charlotte L","family":"Lea","sequence":"first","affiliation":[{"name":"Department of Neonatal Neuroscience, St Michael's Hospital, Bristol, UK"},{"name":"School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Smith-Collins","sequence":"additional","affiliation":[{"name":"Department of Neonatal Neuroscience, St Michael's Hospital, Bristol, UK"},{"name":"School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Luyt","sequence":"additional","affiliation":[{"name":"Department of Neonatal Neuroscience, St Michael's Hospital, Bristol, UK"},{"name":"School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,12,23]]},"reference":[{"key":"2025090504024951000_102.2.F176.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7976"},{"key":"2025090504024951000_102.2.F176.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7961"},{"key":"2025090504024951000_102.2.F176.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.12.053"},{"key":"2025090504024951000_102.2.F176.4","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181733f6f"},{"key":"2025090504024951000_102.2.F176.5","unstructured":"http:\/\/www.rcpch.ac.uk\/improving-child-health\/quality-improvement-and-clinical-audit\/national-neonatal-audit-programme-nn-3 . 2016."},{"key":"2025090504024951000_102.2.F176.6","unstructured":"https:\/\/public.vtoxford.org . 2016."},{"key":"2025090504024951000_102.2.F176.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2005.07.004"},{"key":"2025090504024951000_102.2.F176.8","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-305555"},{"key":"2025090504024951000_102.2.F176.9","unstructured":"Department of Health. Report of Department of Health Expert Working Group on neonatal intensive care services. London: Department of Health, 2003."},{"key":"2025090504024951000_102.2.F176.10","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2010.183236"},{"key":"2025090504024951000_102.2.F176.11","doi-asserted-by":"crossref","unstructured":"Roberts D , Dalziel S . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;(3):CD004454. doi:10.1002\/14651858.CD004454.pub2","DOI":"10.1002\/14651858.CD004454.pub2"},{"key":"2025090504024951000_102.2.F176.12","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-199806000-00012"},{"key":"2025090504024951000_102.2.F176.13","unstructured":"Preterm labour and birth. NICE guidelines (NG25), 2015."},{"key":"2025090504024951000_102.2.F176.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60580-8"},{"key":"2025090504024951000_102.2.F176.15","unstructured":"Royal College of Paediatrics and Child Health. National Neonatal Audit Programme 2015 Annual Report on 2014 data, 2015."},{"key":"2025090504024951000_102.2.F176.16","unstructured":"Vermont Oxford Network. Database of very low birth weight infants born in 2014. Burlington, VT: Vermont Oxford Network."},{"key":"2025090504024951000_102.2.F176.17","doi-asserted-by":"publisher","DOI":"10.1053\/siny.2001.0065"},{"key":"2025090504024951000_102.2.F176.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7793.2000.00619.x"},{"key":"2025090504024951000_102.2.F176.19","doi-asserted-by":"crossref","unstructured":"Doyle LW , Crowther CA , Middleton P , et al . Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009;(1):CD004661. doi:10.1002\/14651858.CD004661.pub3","DOI":"10.1002\/14651858.CD004661.pub3"},{"key":"2025090504024951000_102.2.F176.20","doi-asserted-by":"crossref","unstructured":"Rabe H , Diaz-Rossello JL , Duley L , et al . Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev 2012;(8):CD003248. doi:10.1002\/14651858.CD003248.pub3","DOI":"10.1002\/14651858.CD003248.pub3"},{"key":"2025090504024951000_102.2.F176.21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpeds.2015.09.068","article-title":"Effects of placental transfusion on neonatal and 18 month outcomes in preterm infants: a randomized controlled trial","volume":"168","author":"Mercer","year":"2016","journal-title":"J Pediatr"},{"key":"2025090504024951000_102.2.F176.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073679"},{"key":"2025090504024951000_102.2.F176.23","doi-asserted-by":"crossref","unstructured":"Fowlie PW , Davis PG , McGuire W . Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2010;(7):CD000174. doi:10.1002\/14651858.CD000174.pub2","DOI":"10.1002\/14651858.CD000174.pub2"},{"key":"2025090504024951000_102.2.F176.24","doi-asserted-by":"publisher","DOI":"10.1159\/000326080"},{"key":"2025090504024951000_102.2.F176.25","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/AOG.0000000000000748","article-title":"Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis","volume":"125","author":"Sotiriadis","year":"2015","journal-title":"Obstet Gynecol"},{"key":"2025090504024951000_102.2.F176.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02751.x"},{"key":"2025090504024951000_102.2.F176.27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2393-13-104","article-title":"Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol","volume":"13","author":"Crowther","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025090504024951000_102.2.F176.28","unstructured":"Roberts D . Antenatal Corticosteroids to reduce Neonatal Morbidity and Mortality . Green\u2014top Guideline No. 7. Royal College of Obstetricians and Gynaecologists, 2010."},{"key":"2025090504024951000_102.2.F176.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910143411604"},{"key":"2025090504024951000_102.2.F176.30","doi-asserted-by":"crossref","unstructured":"Brownfoot FC , Crowther CA , Middleton P . Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2008;(4):CD006764. doi:10.1002\/14651858.CD006764.pub2","DOI":"10.1002\/14651858.CD006764.pub2"},{"key":"2025090504024951000_102.2.F176.31","doi-asserted-by":"crossref","unstructured":"Crowther CA , McKinlay CJD , Middleton P , et al . Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev 2015;(7):CD003935. doi:10.1002\/14651858.CD003935.pub4","DOI":"10.1002\/14651858.CD003935.pub4"},{"key":"2025090504024951000_102.2.F176.32","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(05)63935-9","article-title":"Use of magnesium sulphate in obstetrics","volume":"350","author":"Bennett","year":"1997","journal-title":"Lancet"},{"key":"2025090504024951000_102.2.F176.33","doi-asserted-by":"publisher","DOI":"10.1177\/088307389200700113"},{"key":"2025090504024951000_102.2.F176.34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.95.2.263","article-title":"Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?","volume":"95","author":"Nelson","year":"1995","journal-title":"Pediatrics"},{"key":"2025090504024951000_102.2.F176.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g6661"},{"key":"2025090504024951000_102.2.F176.36","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12118"},{"key":"2025090504024951000_102.2.F176.37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1475-097X.2002.00387.x"},{"key":"2025090504024951000_102.2.F176.38","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2004.100.1.0106"},{"key":"2025090504024951000_102.2.F176.39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.11189"},{"key":"2025090504024951000_102.2.F176.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.04.007"},{"key":"2025090504024951000_102.2.F176.41","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-306191"},{"key":"2025090504024951000_102.2.F176.42","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181d4ffa5"},{"key":"2025090504024951000_102.2.F176.43","unstructured":"The Antenatal Magnesium Sulphate for Neuroprotection Guideline Development Panel. Antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child: National clinical practice guidelines. Adelaide: The University of Adelaide, 2010. (www.adelaide.edu.au\/arch)"},{"key":"2025090504024951000_102.2.F176.44","unstructured":"Royal College of Obstetricians and Gynaecologists. Magnesium sulphate to prevent cerebral palsy following preterm birth: Scientific impact paper no. 29, 2011."},{"key":"2025090504024951000_102.2.F176.45","unstructured":"The Royal College of Paediatrics and Child Health. NNAP 2016 Dataset Audit Measures, 2016. http:\/\/www.rcpch.ac.uk\/system\/files\/protected\/page\/2016 audit measures.v.1.pdf"},{"key":"2025090504024951000_102.2.F176.46","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-305884"},{"key":"2025090504024951000_102.2.F176.47","doi-asserted-by":"crossref","first-page":"94.e1","DOI":"10.1016\/j.ajog.2014.07.023","article-title":"Antenatal magnesium sulfate exposure and acute cardiorespiratory events in preterm infants","volume":"212","author":"De Jesus","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"2025090504024951000_102.2.F176.48","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/1471-0528.13460","article-title":"Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth","volume":"123","author":"Kamyar","year":"2016","journal-title":"BJOG"},{"key":"2025090504024951000_102.2.F176.49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-13-91"},{"key":"2025090504024951000_102.2.F176.50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)24047-X"},{"key":"2025090504024951000_102.2.F176.51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.jp.7211419","article-title":"Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor","volume":"26","author":"Mittendorf","year":"2006","journal-title":"J Perinatol"},{"key":"2025090504024951000_102.2.F176.52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejogrb.2016.03.048","article-title":"Magnesium sulphate and perinatal mortality and morbidity in very-low-birthweight infants born between 24 and 32\u2005weeks of gestation in Japan","volume":"201","author":"Ohhashi","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025090504024951000_102.2.F176.53","doi-asserted-by":"crossref","unstructured":"Bain E , Middleton P , Crowther CA . Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth. Cochrane Database Syst Rev 2012;(2):CD009302. doi:10.1002\/14651858.CD009302.pub2","DOI":"10.1002\/14651858.CD009302.pub2"},{"key":"2025090504024951000_102.2.F176.54","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12018"},{"key":"2025090504024951000_102.2.F176.55","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-307655"},{"key":"2025090504024951000_102.2.F176.56","doi-asserted-by":"crossref","first-page":"E372","DOI":"10.1542\/peds.2012-3979","article-title":"Neonatal infection and 5-year neurodevelopmental outcome of very preterm infants","volume":"132","author":"Mitha","year":"2013","journal-title":"Pediatrics"},{"key":"2025090504024951000_102.2.F176.57","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/OGX.0000000000000236","article-title":"Infections and brain development","volume":"70","author":"Cordeiro","year":"2015","journal-title":"Obstet Gynecol Surv"},{"issue":"1","key":"2025090504024951000_102.2.F176.58","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0378-3782(14)70003-9","article-title":"The role of the placenta in feto-neonatal infections","volume":"90","author":"Spinillo","year":"2014","journal-title":"Early Hum Dev"},{"key":"2025090504024951000_102.2.F176.59","unstructured":"Preterm Prelabour Rupture of Membranes Green-top Guideline No 44. Royal College of Obstetrics and Gynaecology, 2006 (minor corrections 2010)."},{"key":"2025090504024951000_102.2.F176.60","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2013.128"},{"key":"2025090504024951000_102.2.F176.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.05.042"},{"key":"2025090504024951000_102.2.F176.62","doi-asserted-by":"crossref","unstructured":"Kenyon S , Boulvain M , Neilson JP . Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2013;(12):CD001058. doi:10.1002\/14651858.CD001058.pub3","DOI":"10.1002\/14651858.CD001058.pub3"},{"key":"2025090504024951000_102.2.F176.63","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61202-7"},{"key":"2025090504024951000_102.2.F176.64","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61203-9"},{"key":"2025090504024951000_102.2.F176.65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604183341601"},{"key":"2025090504024951000_102.2.F176.66","doi-asserted-by":"crossref","unstructured":"Buchanan SL , Crowther CA , Levett KM , et al . Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks\u2019 gestation for improving pregnancy outcome. Cochrane Database Syst Rev 2010;(3):CD004735. doi:10.1002\/14651858.CD004735.pub3","DOI":"10.1002\/14651858.CD004735.pub3"},{"key":"2025090504024951000_102.2.F176.67","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00724-2"},{"key":"2025090504024951000_102.2.F176.68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001208"},{"key":"2025090504024951000_102.2.F176.69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1824-7288-36-63","article-title":"Actualities on molecular pathogenesis and repairing processes of cerebral damage in perinatal hypoxic-ischemic encephalopathy","volume":"36","author":"Distefano","year":"2010","journal-title":"Ital J Pediatr"},{"key":"2025090504024951000_102.2.F176.70","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000324"},{"key":"2025090504024951000_102.2.F176.71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/OGX.0000000000000263","article-title":"Delayed cord clamping in preterm neonates: a review of benefits and risks","volume":"71","author":"Brocato","year":"2016","journal-title":"Obstet Gynecol Surv"},{"key":"2025090504024951000_102.2.F176.72","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.4103\/1673-5374.165218","article-title":"Enhancing endogenous stem cells in the newborn via delayed umbilical cord clamping","volume":"10","author":"Lawton","year":"2015","journal-title":"Neural Regen Res"},{"key":"2025090504024951000_102.2.F176.73","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1542\/peds.2010-2972B","article-title":"Neonatal resuscitation: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations","volume":"126","author":"Perlman","year":"2010","journal-title":"Pediatrics"},{"key":"2025090504024951000_102.2.F176.74","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/trf.13424","article-title":"Delayed clamping of the umbilical cord after delivery and implications for public cord blood banking","volume":"56","author":"Allan","year":"2016","journal-title":"Transfusion"},{"key":"2025090504024951000_102.2.F176.75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1745-6215-15-258","article-title":"Cord pilot trial\u2014immediate versus deferred cord clamping for very preterm birth (before 32\u2005weeks gestation): study protocol for a randomized controlled trial","volume":"15","author":"Pushpa-Rajah","year":"2014","journal-title":"Trials"},{"key":"2025090504024951000_102.2.F176.76","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-135"},{"key":"2025090504024951000_102.2.F176.77","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/AOG.0000000000000122","article-title":"Time to implement delayed cord clamping","volume":"123","author":"McAdams","year":"2014","journal-title":"Obstet Gynecol"},{"key":"2025090504024951000_102.2.F176.78","doi-asserted-by":"crossref","unstructured":"Henderson-Smart DJ , De Paoli AG . Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev 2010;(12):CD000140. doi:10.1002\/14651858.CD000140.pub2","DOI":"10.1002\/14651858.CD000140.pub2"},{"key":"2025090504024951000_102.2.F176.79","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.6.1216"},{"key":"2025090504024951000_102.2.F176.80","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2015.72"},{"key":"2025090504024951000_102.2.F176.81","doi-asserted-by":"crossref","unstructured":"Henderson-Smart DJ , De Paoli AG . Prophylactic methylxanthine for prevention of apnoea in preterm infants. Cochrane Database Syst Rev 2010;(12):CD000432. doi:10.1002\/14651858.CD000432.pub2","DOI":"10.1002\/14651858.CD000432.pub2"},{"key":"2025090504024951000_102.2.F176.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.12.025"},{"key":"2025090504024951000_102.2.F176.83","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2012.52"},{"key":"2025090504024951000_102.2.F176.84","unstructured":"Prophylactic Versus Therapeutic Caffeine for Apnea of Prematurity: Mansoura University Children Hospital. http:\/\/www.clinicaltrials.gov NCT0267758485."},{"key":"2025090504024951000_102.2.F176.85","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.2024"},{"key":"2025090504024951000_102.2.F176.86","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-306176"},{"key":"2025090504024951000_102.2.F176.87","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-3506"},{"key":"2025090504024951000_102.2.F176.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2015.03.004"},{"key":"2025090504024951000_102.2.F176.89","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-304695"},{"key":"2025090504024951000_102.2.F176.90","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-3431"},{"key":"2025090504024951000_102.2.F176.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2013.09.007"},{"key":"2025090504024951000_102.2.F176.92","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/jp.2013.127","article-title":"A risk prediction model for severe intraventricular hemorrhage in very low birth weight infants and the effect of prophylactic indomethacin","volume":"34","author":"Luque","year":"2014","journal-title":"J Perinatol"},{"key":"2025090504024951000_102.2.F176.93","unstructured":"Early Prophylactic Indomethacin Administration To Infants >28weeks Without Optimal Antenatal Steroid Exposure Markedly Reduces the Subsequent Development of Severe Intraventricular Hemorrhage. PAS Meeting 2014; 2014; Vancouver, B.C."},{"key":"2025090504024951000_102.2.F176.94","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00431-016-2705-y","article-title":"Nonsteroidal anti-inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals","volume":"175","author":"Slaughter","year":"2016","journal-title":"Eur J Pediatr"},{"key":"2025090504024951000_102.2.F176.95","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1651-2227.2011.02216.x","article-title":"Why would a sane clinician not prescribe prophylactic indomethacin?","volume":"100","author":"DeMauro","year":"2011","journal-title":"Acta Paediatr"},{"key":"2025090504024951000_102.2.F176.96","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.3.485"},{"key":"2025090504024951000_102.2.F176.97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.07.035"},{"key":"2025090504024951000_102.2.F176.98","doi-asserted-by":"crossref","unstructured":"Bruschettini M , Romantsik O , Zappettini S , et al . Transcutaneous carbon dioxide monitoring for the prevention of neonatal morbidity and mortality. Cochrane Database Syst Rev 2016;(2):CD011494. doi:10.1002\/14651858.CD011494.pub2","DOI":"10.1002\/14651858.CD011494.pub2"},{"key":"2025090504024951000_102.2.F176.99","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.082008"},{"key":"2025090504024951000_102.2.F176.100","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2012.06.009"},{"key":"2025090504024951000_102.2.F176.101","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jpeds.2015.11.017","article-title":"Neonatal infection and later neurodevelopmental risk in the very preterm infant","volume":"170","author":"Rand","year":"2016","journal-title":"J Pediatr"},{"key":"2025090504024951000_102.2.F176.102","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jped.2013.10.002","article-title":"Association of late-onset neonatal sepsis with late neurodevelopment in the first two years of life of preterm infants with very low birth weight","volume":"90","author":"Hentges","year":"2014","journal-title":"J Pediatr (Rio J)"},{"key":"2025090504024951000_102.2.F176.103","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.19.2357"},{"key":"2025090504024951000_102.2.F176.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.09.011"},{"key":"2025090504024951000_102.2.F176.105","doi-asserted-by":"crossref","first-page":"F562","DOI":"10.1136\/archdischild-2015-309804","article-title":"The impact of a sepsis quality improvement project on neurodisability rates in very low birthweight infants","volume":"101","author":"Davis","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2025090504024951000_102.2.F176.106","unstructured":"Enteral Lactoferrin in Neonates. https:\/\/www.npeu.ox.ac.uk\/elfin"},{"key":"2025090504024951000_102.2.F176.107","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2014-306213"},{"key":"2025090504024951000_102.2.F176.108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.02.033"},{"key":"2025090504024951000_102.2.F176.109","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-0569"},{"key":"2025090504024951000_102.2.F176.110","doi-asserted-by":"publisher","DOI":"10.1016\/S1084-2756(03)00123-4"},{"key":"2025090504024951000_102.2.F176.111","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/QCO.0000000000000269","article-title":"Probiotics for prevention of necrotizing enterocolitis and sepsis in preterm infants","volume":"29","author":"Embleton","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"2025090504024951000_102.2.F176.112","doi-asserted-by":"crossref","unstructured":"Pammi M , Abrams SA . Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2015;(2):CD007137. doi:10.1002\/14651858.CD007137.pub4","DOI":"10.1002\/14651858.CD007137.pub4"},{"key":"2025090504024951000_102.2.F176.113","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211758"},{"key":"2025090504024951000_102.2.F176.114","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2468-1253(16)30117-0","article-title":"Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012\u201313: a whole-population surveillance study","volume":"2","author":"Battersby","year":"2016","journal-title":"Lancet Gastroenterol Herpetol"},{"key":"2025090504024951000_102.2.F176.115","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1463"},{"key":"2025090504024951000_102.2.F176.116","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/dmcn.12415","article-title":"Is melatonin ready to be used in preterm infants as a neuroprotectant?","volume":"56","author":"Biran","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"2025090504024951000_102.2.F176.117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2013.10.040"},{"key":"2025090504024951000_102.2.F176.118","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.semperi.2015.12.002","article-title":"Stem cell-based therapies for the newborn lung and brain: possibilities and challenges","volume":"40","author":"Mitsialis","year":"2016","journal-title":"Semin Perinatol"},{"key":"2025090504024951000_102.2.F176.119","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0211"},{"key":"2025090504024951000_102.2.F176.120","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/apa.13344","article-title":"Nutrition and neurodevelopmental outcomes in preterm infants: a systematic review","volume":"105","author":"Chan","year":"2016","journal-title":"Acta Paediatr"},{"key":"2025090504024951000_102.2.F176.121","doi-asserted-by":"crossref","unstructured":"Belfort MB , Anderson PJ , Nowak PJ , et al . Breast milk feeding, brain development, and neurocognitive outcomes: a 7-year longitudinal study in infants born at less than 30 weeks\u2019 gestation. J Paediatr 2016:133\u20139. doi:10.1016\/j.jpeds.2016.06.045","DOI":"10.1016\/j.jpeds.2016.06.045"},{"key":"2025090504024951000_102.2.F176.122","doi-asserted-by":"crossref","first-page":"E115","DOI":"10.1542\/peds.2005-2382","article-title":"Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18\u2005months of age","volume":"118","author":"Vohr","year":"2006","journal-title":"Pediatrics"},{"key":"2025090504024951000_102.2.F176.123","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/pr.2016.114","article-title":"Human milk intake in preterm infants and neurodevelopment at 18\u2005months corrected age","volume":"80","author":"Jacobi-Polishook","year":"2016","journal-title":"Pediatr Res"},{"key":"2025090504024951000_102.2.F176.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2013.07.003"},{"key":"2025090504024951000_102.2.F176.125","doi-asserted-by":"crossref","first-page":"E852","DOI":"10.1542\/peds.2009-1960","article-title":"Randomized trial of drainage, irrigation and fibrinolytic therapy for premature infants with posthemorrhagic ventricular dilatation: developmental outcome at 2\u2005years","volume":"125","author":"Whitelaw","year":"2010","journal-title":"Pediatrics"},{"key":"2025090504024951000_102.2.F176.126","doi-asserted-by":"crossref","unstructured":"Spittle A , Orton J , Anderson P , et al . Early developmental intervention programmes post-hospital discharge to prevent motor and cognitive impairments in preterm infants. Cochrane Database Syst Rev 2012;(12):CD005495. doi:10.1002\/14651858.CD005495.pub3","DOI":"10.1002\/14651858.CD005495.pub3"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2016-311949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:03:21Z","timestamp":1757070201000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2016-311949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,23]]},"references-count":126,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,16]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1136\/archdischild-2016-311949"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2016-311949","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,23]]}}}